Continuous preparation method and continuous preparation system of limonidine

Through continuous preparation method and heterogeneous catalyst fixed bed reactor, the existing rimenidine synthesis process is solved, and efficient and stable rimenidine custom preparation is achieved, which improves the total yield and purity.

CN118994045AActive Publication Date: 2024-11-22XIAN CHILDRENS HOSPITAL
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411103362.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-22
Estimated Expiration
2044-08-13

AI Technical Summary

Technical Problem

The existing rimenidine synthesis method has complex processes, rare raw materials, high costs, harsh reaction conditions, low total yield, and room for optimization.

Method used

The continuous preparation method is adopted to achieve the efficient preparation of rimenidine by reacting hydrogenation and substitution dehydration of bicyclopropyl ketone with 2-oxazolidinone, and a continuous process is carried out using a heterogeneous catalyst fixed bed reactor.

Benefits of technology

It improves production efficiency and product stability, shortens the process route, improves the total yield and purity, reduces by-products and energy consumption, and reduces raw material costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994045A_ABST
    Figure CN118994045A_ABST
Patent Text Reader

Abstract

The invention discloses a continuous preparation method and a continuous preparation system of limonidine. The method comprises the following steps: introducing hydrogen-ammonia mixed gas and feed liquid A containing dicyclopropyl ketone into a fixed bed reactor I to carry out oximation hydrogenation reaction; carrying out gas-liquid separation, drying and degassing on the reacted system to obtain a degassed system; inputting nitrogen, the degassed system and a feed liquid B containing 2-oxazolidinone, a reaction auxiliary agent and a cosolvent into a fixed bed reactor II for substitution dehydrogenation reaction; and washing the reacted system, splitting phases, drying, filtering, evaporating to dryness, and recrystallizing to obtain the limonidine. According to the method disclosed by the invention, the dicyclopropyl ketone is subjected to oximation hydrogenation reaction continuously and then is subjected to substitution dehydration with 2-oxazolidinone, so that the limonidine is prepared, the total reaction conversion rate can be stabilized at 90.7% at most after continuous operation for 200h, and the method has the characteristics of higher production efficiency and better product stability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug synthesis, and particularly relates to a continuous preparation method and a continuous preparation system of rilmenidine. Background Art

[0002] Prevention and treatment of hypertension is of great significance in reducing organ damage and complications. The number of drugs for the treatment of cardiovascular diseases is gradually increasing.

[0003] Among them, Rilmenidine is one of the representatives of the second-generation central antihypertensive drugs, developed by Servier, France. Because the drug selectively acts on the II-imidazoline receptors in the ventrolateral nucleus of the medulla oblongata, it is also called imidazoline receptor antagonist (N-(dicyclopropylmethyl)-4,5-dihydro-2-oxazolamide). Rilmenidine has a weak effect on α-2 adrenergic receptors and has no obvious central sedative effect. It exerts its antihypertensive effect by binding to imidazoline receptors. The antihypertensive effect is stable and reliable. It has the advantages of good tolerance, few side effects, good safety, and significant efficacy in clinical practice.

[0004] There are two main routes for the synthesis of rilmenidine reported so far, and both are step-by-step preparation processes. One is to heat cyclization of 2-chloroethyl isocyanate and dicyclopropylmethylamine in the presence of potassium fluoride supported on alumina (Biooranic & Medicinal Chemistry Letters 1994, 4, 2317-22). The other is to use chloroisocyanate as raw material and dicyclopropylmethylamine to obtain it through continuous two-step reaction (DE2362754). However, the raw materials of these two methods are not easy to obtain. When preparing these two raw materials, it is necessary to undergo multi-step chemical reactions, the process is complicated, and the price is expensive. CN1629144A discloses a method for preparing rilmenidine by condensation of 2-alkoxy oxazoline and dicyclopropylmethylamine, which simplifies the previous complicated production process to a certain extent. However, its raw material dicyclopropylmethylamine still adopts a step-by-step synthesis method of generating oxime from dicyclopropyl ketone and then hydrogenating and reducing. The total yield of the whole synthetic route is less than 70%. Qiang Yongkang reported a method of using nickel to catalyze the hydrogenation of dicyclopropyl ketone with ammonia in one pot to directly obtain dicyclopropyl methylamine, a key intermediate, and then using boron trifluoride etherate and hydrochloropropane as basic raw materials with 2-oxazolidinone to prepare another key intermediate 2-ethoxy oxazoline, and then the two intermediates were combined to obtain the product rilmenidine. The total yield of the entire synthetic route reached 80%, which greatly improved the problem of rare raw materials and high cost in traditional processes.

[0005] However, the reaction conditions of the above routes are still relatively harsh, there are many reaction steps, the post-processing is cumbersome, the overall reaction yield is not high, the cost is high, and there is still a lot of room for optimization from the perspective of industrial production. Summary of the invention

[0006] The technical problem to be solved by the present invention is to provide a continuous preparation method and a continuous preparation system of rilmenidine in view of the deficiencies of the above-mentioned prior art. The present invention provides a method for continuously preparing rilmenidine, wherein rilmenidine is continuously prepared by carrying out an oximation hydrogenation reaction of dicyclopropyl ketone and then performing substitution dehydration with 2-oxazolidinone, and the total conversion rate of the reaction can be stabilized at a maximum of 90.7% after continuous operation for 200 hours, and the method has the characteristics of higher production efficiency and better product stability.

[0007] In order to solve the above technical problems, the technical solution adopted by the present invention is: a continuous preparation method of rilmenidine, characterized in that the synthesis route of the method is as follows:

[0008]

[0009] The above-mentioned continuous preparation method of rilmenidine is characterized by comprising:

[0010] Step 1, mixing dicyclopropyl ketone with an organic solvent to obtain a feed liquid A;

[0011] Step 2, preheating the hydrogen-ammonia mixture to 30-80°C and then passing it into a fixed bed reactor I equipped with a heterogeneous catalyst until the pressure in the fixed bed reactor I equipped with a heterogeneous catalyst is 0.1-2MPa.G and maintained, setting the temperature of the fixed bed reactor I equipped with a heterogeneous catalyst to 30-80°C and maintaining it, preheating the feed liquid A to 30-80°C and then passing it into the fixed bed reactor I equipped with a heterogeneous catalyst at a flow rate of 0.1mL / min-5mL / min for oximation hydrogenation reaction;

[0012] Step 3, separating the gas-liquid phase of the system after the reaction in step 2 to obtain a liquid phase system;

[0013] Step 4, drying and degassing the liquid phase system to obtain a degassed system;

[0014] Step 5, mixing 2-oxazolidinone and the reaction aid solution with the co-solvent to obtain a feed solution B;

[0015] Step 6, preheating nitrogen to 50-100° C. and then passing it into a fixed bed reactor II filled with a heterogeneous catalyst until the pressure in the fixed bed reactor II filled with a heterogeneous catalyst is 1 atm and maintained, setting the temperature of the fixed bed reactor II filled with a heterogeneous catalyst to 50-100° C. and maintaining it, mixing the degassed system in step 4 and the feed liquid B in step 5 at a volume ratio of 1: (1-1.2) to obtain a mixture, preheating the mixture to 50-100° C. and then inputting it into a fixed bed reactor II filled with a heterogeneous catalyst at a flow rate of 0.1 mL / min-5 mL / min for substitution dehydrogenation reaction;

[0016] Step 7, washing the system after the reaction in step 6, separating the phases to obtain an organic phase, drying the organic phase, filtering, and evaporating to dryness to obtain a crude product;

[0017] Step eight, recrystallizing the crude product to obtain rilmenidine.

[0018] The above-mentioned continuous preparation method of rilmenidine is characterized in that, in step 1, the organic solvent is one or more of alcohols, ethers, nitriles, esters, alkanes, halogenated hydrocarbons and aromatic hydrocarbons; the alcohol organic solvent is methanol, anhydrous ethanol, isopropanol or tert-butyl alcohol; the ether organic solvent is ethyl ether, tetrahydrofuran, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether; the nitrile organic solvent is acetonitrile or propionitrile; the ester organic solvent is methyl acetate, Ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, isoamyl acetate, methyl propionate, ethyl propionate, propyl propionate, dimethyl carbonate, diethyl carbonate or ethyl methyl carbonate; the alkane organic solvent is n-pentane, n-heptane, n-hexane, cyclohexane or petroleum ether; the halogenated hydrocarbon organic solvent is dichloromethane or 1,2-dichloroethane; the aromatic hydrocarbon organic solvent is benzene, toluene, xylene, chlorobenzene, o-dichlorobenzene, m-dichlorobenzene or p-dichlorobenzene.

[0019] The above-mentioned continuous preparation method of rilmenidine is characterized in that, in step 1, the concentration of dicyclopropyl ketone in the feed liquid A is 5 to 50 g / L.

[0020] The above-mentioned continuous preparation method of rilmenidine is characterized in that, in step 2, the average residence time of the feed liquid A in the fixed bed reactor I equipped with a heterogeneous catalyst is 3 to 5 h, and the volume ratio of hydrogen and ammonia in the hydrogen-ammonia mixture is (1 to 10): 1; in step 2, the hydrogen-ammonia mixture flow rate is 1 to 50 mL / min; in step 2, the mass of the heterogeneous catalyst is 1 to 50 g; in step 2, the heterogeneous catalyst is a metal-supported heterogeneous catalyst, and the mass percentage of the metal in the metal-supported heterogeneous catalyst is 0.5% to 15%; in step 2, the heterogeneous catalyst morphology is spherical or columnar, with a particle size range of 0.5 mm to 4 mm, and the heterogeneous catalyst is a rhodium-based heterogeneous carrier catalyst, a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst, and a platinum-based heterogeneous carrier catalyst. One or two.

[0021] The above-mentioned continuous preparation method of rilmenidine is characterized in that, in step five, the reaction aid solution is a reaction aid solution obtained by dissolving a reaction aid in ether, and the reaction aid is boron trifluoride or tetrafluoroboric acid; in step five, in the feed solution B, the concentration of 2-oxazolidinone is 4 to 40 g / L, and the molar ratio of 2-oxazolidinone to the reaction aid is 1: (1 to 5).

[0022] The above-mentioned continuous preparation method of rilmenidine is characterized in that, in step 5, the cosolvent is one or more of alcohols, ethers, nitriles, esters, alkanes, halogenated hydrocarbons and aromatic hydrocarbons; the alcohol cosolvent is methanol, anhydrous ethanol, isopropanol or tert-butyl alcohol; the ether cosolvent is ether, tetrahydrofuran, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether; the nitrile cosolvent is acetonitrile or propionitrile; the ester cosolvent is methyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, ethyl acetate, The co-solvents are ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, isoamyl acetate, methyl propionate, ethyl propionate, propyl propionate, dimethyl carbonate, diethyl carbonate or ethyl methyl carbonate; the co-solvents are n-pentane, n-heptane, n-hexane, cyclohexane or petroleum ether; the co-solvents are dichloromethane or 1,2-dichloroethane; the co-solvents are benzene, toluene, xylene, chlorobenzene, o-dichlorobenzene, m-dichlorobenzene or p-dichlorobenzene.

[0023] The above-mentioned continuous preparation method of rilmenidine is characterized in that, in step six, the average residence time of the mixture in the fixed bed reactor II containing a heterogeneous catalyst is 4 to 10 hours; in step six, the mass of the heterogeneous catalyst is 2g to 100g; in step six, the heterogeneous catalyst is a metal-supported heterogeneous catalyst, and the mass percentage of the metal in the metal-supported heterogeneous catalyst is 0.1% to 10%; in step six, the heterogeneous catalyst has a spherical or columnar morphology, a particle size range of 0.2mm to 4mm, and the heterogeneous catalyst is one or two of a rhodium-based heterogeneous carrier catalyst, a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst and a platinum-based heterogeneous carrier catalyst.

[0024] The above-mentioned continuous preparation method of rilmenidine is characterized in that in step six, the heterogeneous catalyst is one or two of a rhodium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst and a platinum-based heterogeneous carrier catalyst.

[0025] In addition, the present invention also provides a continuous preparation system of rilmenidine, characterized in that the system comprises a fixed bed reactor I for carrying out oximation hydrogenation reaction and a fixed bed reactor II for carrying out substitution dehydrogenation reaction, and the fixed bed reactor I is connected to the fixed bed reactor II.

[0026] Compared with the prior art, the present invention has the following advantages:

[0027] 1. The method for continuously preparing rilmenidine of the present invention comprises the following steps: performing an oximation hydrogenation reaction of dicyclopropyl ketone and then performing substitution dehydration with 2-oxazolidinone to continuously prepare rilmenidine. The total conversion rate of the reaction can be stabilized at up to 90.7% after continuous operation for 200 hours, and the method has the characteristics of higher production efficiency and better product stability.

[0028] 2. The system for continuously preparing rilmenidine of the present invention connects two fixed-bed reactors in series to realize the two-step reaction in the synthesis process. The cascade reaction process assisted by drying and degassing has the characteristics of high reaction efficiency and few by-products, which can effectively reduce the influence of a large number of post-processing steps such as extraction, evaporation, filtration and purification in traditional processes on the product.

[0029] 3. The method for continuously preparing rilmenidine of the present invention greatly shortens the length of the original process route. The hydrogenation and dehydrogenation are carried out successively through catalytic reactions, which greatly simplifies the complicated oximation and substitution reactions in the previous process route. The total yield of the route can reach 85.8%, and the purity of the target product can reach 99.1%. It has the characteristics of high conversion rate, mild reaction process, easy control of the reaction process, few by-products, and low energy consumption.

[0030] 4. The raw and auxiliary materials of the method for continuously preparing rilmenidine of the present invention are all commercially available and inexpensive, thus avoiding the use of expensive and highly toxic isocyanate compounds.

[0031] The technical solution of the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments.

[0032] Instruction Manual

[0033] Figure 1 This is a schematic diagram of the structure of the system for continuously preparing rilmenidine in Example 16 of the present invention. DETAILED DESCRIPTION

[0034] The specific embodiments of the present invention are described in detail below. It should be understood that the specific embodiments described herein are only used to illustrate and explain the present invention, and are not used to limit the present invention.

[0035] The endpoints and any values ​​of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values ​​should be understood to include values ​​close to these ranges or values. For numerical ranges, the endpoint values ​​of each range, the endpoint values ​​of each range and the individual point values, and the individual point values ​​can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.

[0036] The present invention will be described in detail below by way of examples. In the following examples, unless otherwise specified, the raw materials used are all commercially available industrial grade products.

[0037] The present invention provides a continuous preparation method of rilmenidine, and the process route is:

[0038]

[0039] The continuous preparation method of the above-mentioned rilmenidine of the present invention comprises: continuously inputting a feed liquid A obtained by mixing dicyclopropyl ketone and an organic solvent into a fixed bed reactor I filled with a hydrogen-ammonia mixed gas to carry out an oximation hydrogenation reaction, separating the system after the oximation hydrogenation reaction by gas-liquid separation, drying and degassing to obtain a degassed system, continuously inputting the degassed system and a feed liquid B containing 2-oxazolidinone into a fixed bed reactor II for a substitution dehydrogenation reaction, and washing, phase separation, and recrystallization of the system after the substitution dehydrogenation reaction to obtain rilmenidine, specifically comprising:

[0040] Step 1, mixing dicyclopropyl ketone with an organic solvent to obtain a feed liquid A; the organic solvent can be one or more of alcohols, ethers, nitriles, esters, alkanes, halogenated hydrocarbons and aromatic hydrocarbons, the alcohol organic solvent can be methanol, anhydrous ethanol, isopropanol or tert-butanol, the ether organic solvent can be ether, tetrahydrofuran, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether; the nitrile organic solvent can be acetonitrile or propionitrile, the ester organic solvent can be methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, isopentyl acetate, methyl propionate, ethyl propionate, propyl propionate, dimethyl carbonate, diethyl carbonate or carbonyl carbonate. The alkane organic solvent may be n-pentane, n-heptane, n-hexane, cyclohexane or petroleum ether, the halogenated hydrocarbon organic solvent may be dichloromethane or 1,2-dichloroethane, and the aromatic hydrocarbon organic solvent may be benzene, toluene, xylene, chlorobenzene, o-dichlorobenzene, m-dichlorobenzene or p-dichlorobenzene. For example, the organic solvent may be anhydrous ethanol, tetrahydrofuran, methyl acetate, n-heptane, dichloromethane, toluene or m-dichlorobenzene, or a mixture of any one or more of the above organic solvents. The concentration of dicyclopropyl ketone in the feed liquid A is 5 to 50 g / L, and the concentration may be, for example, 5 g / L, 50 g / L or 20 g / L.

[0041] Step 2: preheat the hydrogen-ammonia mixture to 30-80°C and then pass it into a fixed bed reactor I equipped with a heterogeneous catalyst until the pressure in the fixed bed reactor I equipped with a heterogeneous catalyst is 0.1-2 MPa.G and maintained, set the temperature of the fixed bed reactor I equipped with a heterogeneous catalyst to 30-80°C and maintain it, preheat the feed liquid A to 30-80°C and then pass it into the fixed bed reactor equipped with a heterogeneous catalyst at a flow rate of 0.1 mL / min-5 mL / min. An oximation hydrogenation reaction is carried out in a fixed bed reactor I; the average residence time of the feed liquid A in the fixed bed reactor I equipped with a heterogeneous catalyst is 3 to 5 hours, for example, 3 hours, 4 hours or 5 hours; the volume ratio of hydrogen to ammonia in the hydrogen-ammonia mixed gas is (1 to 10):1, for example, 1:1, 2:1 or 10:1, and the flow rate of the hydrogen-ammonia mixed gas is 1 to 50 mL / min, for example, 1 mL / min, 30 mL / min or 50 mL / min;

[0042] The mass of the heterogeneous catalyst is 1 to 50 g, for example, 1 g, 10 g or 50 g;

[0043] The heterogeneous catalyst is a metal-supported heterogeneous catalyst, and the mass percentage of the metal in the metal-supported heterogeneous catalyst is 0.5% to 15%, for example, 0.5%, 10% or 15%;

[0044] The metal-supported heterogeneous catalyst has a spherical or columnar morphology and a particle size range of 0.5 mm to 4 mm;

[0045] The preheating temperature of the hydrogen-ammonia mixture, the reactor setting temperature and the preheating temperature of the feed liquid A are equal and are all 30 to 80°C, for example, 30°C, 50°C or 80°C;

[0046] The metal-supported heterogeneous catalyst may be one or two of a rhodium-based heterogeneous carrier catalyst, a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst, and a platinum-based heterogeneous carrier catalyst, for example, a rhodium-based heterogeneous carrier catalyst, a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst, or a platinum-based heterogeneous carrier catalyst, or a combination of two of the above catalysts; the metal form in the metal-supported heterogeneous catalyst may be one or more of a simple substance, an oxide, a chloride, a hydroxide, a sulfate, a carbonate, a nitrate, a phosphate, a borate, a carboxylate, and a sulfonate, and the carrier may be activated carbon, or one or more of aluminum oxide, silicon oxide, zirconium oxide, and magnesium oxide, or a combination of aluminum oxide and one or more of silicon oxide, zirconium oxide, and magnesium oxide;

[0047] The preparation method of the metal-supported heterogeneous catalyst can be an impregnation method commonly used in the art, or other preparation methods. The impregnation method is, for example, to immerse the metal-soluble salt solution and the carrier for 12 hours, and then dry and reduce at 80-150° C. to obtain the catalyst; the drying temperature can be, for example, 80° C., 120° C. or 150° C., and the drying time can be 6 hours, 10 hours or 20 hours; the reduction can be reduction in N2 and / or H2 atmosphere;

[0048] The metal-supported heterogeneous catalyst may further include an auxiliary agent, which may be one or two of NaCl, Mn(NO3)2, Ni(NO3)2·6H2O, CuCl2, Mg(NO3)2·3H2O and Zn(NO3)2·6H2O, or a combination of NaCl and Mn(NO3)2, Ni(NO3)2·6H2O, CuCl2, Mg(NO3)2·3H2O or Zn(NO3)2·6H2O;

[0049] Step 3, separating the gas-liquid phase of the system after the reaction in step 2 to obtain a liquid phase system;

[0050] Step 4, drying and degassing the liquid phase system to obtain a degassed system;

[0051] Step 5, mixing 2-oxazolidinone and a reaction aid solution with a co-solvent to obtain a feed solution B; the reaction aid solution is a reaction aid solution obtained by dissolving a reaction aid in ether, and the reaction aid is boron trifluoride or tetrafluoroboric acid;

[0052] In the feed solution B, the concentration of 2-oxazolidinone is 4 to 40 g / L, such as 4 g / L, 20 g / L or 40 g / L; the molar ratio of 2-oxazolidinone to the reaction aid is 1:(1 to 5), such as 1:1, 1:2 or 1:5;

[0053] The cosolvent can be one or more of alcohols, ethers, nitriles, esters, alkanes, halogenated hydrocarbons and aromatic hydrocarbons. The alcohol cosolvent can be methanol, anhydrous ethanol, isopropanol or tert-butyl alcohol. The ether cosolvent can be ethyl ether, tetrahydrofuran, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether. The nitrile cosolvent can be acetonitrile or propionitrile. The ester cosolvent can be methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, isopentyl acetate, methyl propionate Ester, ethyl propionate, propyl propionate, dimethyl carbonate, diethyl carbonate or ethyl methyl carbonate, the alkane cosolvent may be n-pentane, n-heptane, n-hexane, cyclohexane or petroleum ether, the halogenated hydrocarbon cosolvent may be dichloromethane or 1,2-dichloroethane, the aromatic hydrocarbon cosolvent may be benzene, toluene, xylene, chlorobenzene, o-dichlorobenzene, m-dichlorobenzene or p-dichlorobenzene, for example, the cosolvent may be the same as in step 1, or may be a mixture of any one or more of the above cosolvents;

[0054] Step 6: Preheat nitrogen to 50-100° C. and then pass it into a fixed bed reactor II containing a heterogeneous catalyst until the pressure in the fixed bed reactor II containing a heterogeneous catalyst is 1 atm and maintained, set the temperature of the fixed bed reactor II containing a heterogeneous catalyst to 50-100° C. and maintain it, mix the degassed system in step 4 and the feed liquid B in step 5 at a volume ratio of 1: (1-1.2) to obtain a mixture, preheat the mixture to 50-100° C. and then precipitate at 0.1 mL / min-5 mL / min. min flow rate into a fixed bed reactor II equipped with a heterogeneous catalyst for substitution dehydrogenation reaction; the volume ratio may be, for example, 1:1.05, 1:1.2 or 1:1.1; the preheating temperature may be, for example, 50°C, 80°C or 100°C, and the flow rate may be, for example, 0.1 mL / min, 2 mL / min or 5 mL / min; the average residence time of the mixture in the fixed bed reactor II equipped with a heterogeneous catalyst is 4 to 10 h, and the average residence time may be, for example, 4 h, 8 h or 10 h;

[0055] The mass of the heterogeneous catalyst is 2g to 100g, for example, 2g, 10g or 100g; the heterogeneous catalyst is a metal-supported heterogeneous catalyst; the mass percentage of the metal in the metal-supported heterogeneous catalyst is 0.1% to 10%, for example, 0.1%, 5% or 10%; the metal-supported heterogeneous catalyst has a spherical or columnar morphology, and a particle size range of 0.2mm to 4mm;

[0056] The metal-supported heterogeneous catalyst can be one or two of a rhodium-based heterogeneous carrier catalyst, a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst and a platinum-based heterogeneous carrier catalyst, for example, a rhodium-based heterogeneous carrier catalyst, a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst or a platinum-based heterogeneous carrier catalyst, or a combination of two of the above catalysts; the metal form in the metal-supported heterogeneous catalyst can be one or more of a simple substance, an oxide, a chloride, a hydroxide, a sulfate, a carbonate, a nitrate, a phosphate, a borate, a carboxylate and a sulfonate, and the carrier is one or more of graphite, talc, activated carbon, SiO2, Al2O3 and diatomaceous earth; preferably, the metal-supported heterogeneous catalyst The catalyst is one or two of a rhodium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst and a platinum-based heterogeneous carrier catalyst; further preferably, when the metal-supported heterogeneous catalyst in step six is ​​a rhodium-based heterogeneous carrier catalyst, the metal-supported heterogeneous catalyst in step two is one or two of a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst and a platinum-based heterogeneous carrier catalyst, when the metal-supported heterogeneous catalyst in step six is ​​a palladium-based heterogeneous carrier catalyst and / or a platinum-based heterogeneous carrier catalyst, the metal-supported heterogeneous catalyst in step two is one or two of a rhodium-based heterogeneous carrier catalyst, a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst and a platinum-based heterogeneous carrier catalyst;

[0057] The preparation method of the metal-supported heterogeneous catalyst may be the same as step 2;

[0058] Step 7, washing the system after the reaction in step 6 with saturated brine, separating the phases to obtain an organic phase, drying the organic phase, filtering, and evaporating to dryness to obtain a crude product; the drying is drying with anhydrous sodium sulfate;

[0059] Step eight, recrystallizing the crude product to obtain rilmenidine; the solvent for the recrystallization is ethyl acetate or n-hexane; the melting point of the recrystallization is 105-107°C.

[0060] Example 1

[0061] This embodiment provides a continuous preparation method of rilmenidine, which specifically comprises:

[0062] Step 1, mixing dicyclopropyl ketone with an organic solvent to obtain a feed liquid A; the organic solvent is anhydrous ethanol; the concentration of dicyclopropyl ketone in the feed liquid A is 5 g / L;

[0063] Step 2, preheating the hydrogen-ammonia mixture to 40°C and then passing it into a fixed bed reactor I equipped with a palladium-based heterogeneous catalyst, until the pressure in the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst is 0.5MPa.G and maintained, setting the temperature of the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst to 40° and maintaining it, preheating the feed liquid A to 40°C and passing it into the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst at a flow rate of 1mL / min for oximation hydrogenation reaction; the average residence time of the feed liquid A in the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst is 3h; the hydrogen-ammonia mixture The volume ratio of hydrogen to ammonia is 1:1, the mass of the palladium-based heterogeneous catalyst is 10 g, the palladium-based heterogeneous catalyst is a palladium-based heterogeneous catalyst with activated carbon as a carrier to load palladium, the mass percentage of palladium in the palladium-based heterogeneous catalyst is 1%, and the mass percentage of palladium = metal palladium / the palladium-based heterogeneous catalyst; the palladium-based heterogeneous catalyst has a spherical morphology and a particle size range of 0.5 mm to 4 mm; the palladium-based heterogeneous catalyst may also have a columnar morphology; the hydrogen-ammonia mixed gas flow rate introduced to maintain the pressure in the fixed bed reactor I equipped with the palladium-based heterogeneous catalyst is 30 mL / min;

[0064] Step 3: Perform gas-liquid separation on the system after the reaction in step 2 to obtain a liquid phase system; the gas-liquid separation can separate hydrogen and ammonia for recycling;

[0065] Step 4, drying and degassing the liquid phase system to obtain a degassed system; the drying is performed using a 4A molecular sieve; the degassing is performed by bubbling degassing, the degassing is performed using nitrogen, the nitrogen flow rate is 100 mL / min, and the degassing time is 2 h;

[0066] Step 5, 2-oxazolidinone and a reaction aid solution are mixed with a solvent to obtain a feed liquid B; the reaction aid solution is a boron trifluoride ether solution, the reaction aid is boron trifluoride, the solvent is tetrahydrofuran, the mass percentage of the boron trifluoride ether solution is 47%, the concentration of 2-oxazolidinone in the feed liquid B is 4g / L, and the molar ratio of 2-oxazolidinone to boron trifluoride is 1:2; 2-oxazolidinone and a reaction aid solution are mixed with a solvent to obtain a feed liquid B; the reaction aid solution is a boron trifluoride ether solution, the reaction aid is boron trifluoride, the solvent is tetrahydrofuran, the mass percentage of the boron trifluoride ether solution is 47%, and the concentration of 2-oxazolidinone in the feed liquid B is 4g / L, and the molar ratio of 2-oxazolidinone to boron trifluoride is 1:2;

[0067] Step six, preheating nitrogen to 80 ° C and then passing it into a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst, until the pressure in the fixed bed reactor II equipped with a platinum-based heterogeneous catalyst is 1atm and maintained, setting the temperature of the fixed bed reactor II equipped with a platinum-based heterogeneous catalyst to 80 ° C and maintaining it, mixing the system after degassing in step 4 and the feed liquid B in step 5 at a volume ratio of 1:1.1 to obtain a mixture, preheating the mixture to 80 ° C and then inputting it into a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst at a flow rate of 2 mL / min for substitution dehydrogenation reaction; the mixture is in a fixed bed reactor equipped with a platinum-based heterogeneous catalyst The average residence time in the fixed bed reactor II is 4h; the mass of the platinum heterogeneous catalyst is 10g, the platinum heterogeneous catalyst is a catalyst loaded with platinum on Al2O3 as a carrier, the mass percentage of platinum in the platinum heterogeneous catalyst is 1%, the morphology of the platinum heterogeneous catalyst is spherical, and the particle size range is 0.2mm-4mm; the morphology of the platinum heterogeneous catalyst can also be columnar; after stable operation for a predetermined time, sampling is performed at the discharge port, and the residual raw materials and product content of the two steps before and after are analyzed to obtain the total conversion rate of the raw materials, and the results are listed in the following Table 1; the predetermined time is 50h, 100h or 200h;

[0068] Step 7, washing the system after the reaction in step 6 with saturated brine, separating the phases to obtain an organic phase, drying the organic phase, filtering, and evaporating to dryness to obtain a crude product; the drying is drying with anhydrous sodium sulfate;

[0069] Step eight, recrystallizing the crude product to obtain rilmenidine; the solvent for the recrystallization is ethyl acetate, and the solvent for the recrystallization can also be n-hexane; the melting point of the recrystallization is 105-107° C.;

[0070] In this embodiment, the purity of pure rilmenidine is shown in Table 1, and the nuclear magnetic resonance and mass spectra are as follows:

[0071] 1 HNMR (CDCl3, 400M): δ (ppm) 3.90 (m, 2H), 3.72 (m, 2H), 2.35 (m, 1H), 1.10 (m, 2H), 0.42 (m, 8H).

[0072] MS: m / z = 180.43 [M+H] +

[0073] Example 2

[0074] This embodiment provides a continuous preparation method of rilmenidine, which specifically comprises:

[0075] Step 1, mixing dicyclopropyl ketone with an organic solvent to obtain a feed liquid A; the organic solvent is ethylene glycol dimethyl ether; the concentration of dicyclopropyl ketone in the feed liquid A is 10 g / L;

[0076] Step 2: preheat the hydrogen-ammonia mixture to 60°C and then pass it into a fixed bed reactor I equipped with a palladium-based heterogeneous catalyst, until the pressure in the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst is 1.0 MPa.G and maintained, set the temperature of the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst to 60°C and maintain it, preheat the feed liquid A to 60°C and then pass it into the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst at a flow rate of 5 mL / min for oximation hydrogenation reaction; the average residence time of the feed liquid A in the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst is The volume ratio of hydrogen to ammonia in the hydrogen-ammonia mixture is 2:1, the mass of the palladium-based heterogeneous catalyst is 20 g, the palladium-based heterogeneous catalyst is a palladium-based heterogeneous catalyst with activated carbon as a carrier supporting palladium, the mass percentage of palladium in the palladium-based heterogeneous catalyst is 2%, the palladium-based heterogeneous catalyst is spherical in shape, and the particle size range is 0.5 mm to 4 mm; the palladium-based heterogeneous catalyst can also be columnar in shape; the hydrogen-ammonia mixture gas flow rate introduced to maintain the pressure in the fixed bed reactor I containing the palladium-based heterogeneous catalyst is 30 mL / min;

[0077] Step 3: Perform gas-liquid separation on the system after the reaction in step 2 to obtain a liquid phase system; the gas-liquid separation can separate hydrogen and ammonia for recycling;

[0078] Step 4, drying and degassing the liquid phase system to obtain a degassed system; the drying is performed using a 4A molecular sieve; the degassing is performed by bubbling degassing, the degassing is performed using nitrogen, the nitrogen flow rate is 100 mL / min, and the degassing time is 2 h;

[0079] Step 5, mixing 2-oxazolidinone and a reaction aid solution with a co-solvent to obtain a feed solution B; the reaction aid solution is a boron trifluoride ether solution, the reaction aid is boron trifluoride, the co-solvent is dichloromethane, the mass percentage of the boron trifluoride ether solution is 47%, the concentration of 2-oxazolidinone in the feed solution B is 8 g / L, and the molar ratio of 2-oxazolidinone to boron trifluoride is 1:2.5;

[0080] Step 6: Preheat nitrogen to 70°C and then pass it into a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst until the pressure in the fixed bed reactor II equipped with a platinum-based heterogeneous catalyst is 1 atm and maintained, set the temperature of the fixed bed reactor II equipped with a platinum-based heterogeneous catalyst to 70°C and maintain it, mix the degassed system in step 4 and the feed liquid B in step 5 at a volume ratio of 1:1.05 to obtain a mixture, preheat the mixture to 70°C and then input it into a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst at a flow rate of 4 mL / min for substitution dehydrogenation reaction; the mixture is in a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst The average residence time is 4h; the mass of the platinum-based heterogeneous catalyst is 20g, the platinum-based heterogeneous catalyst is a catalyst loaded with platinum on Al2O3 as a carrier, the mass percentage of platinum in the platinum-based heterogeneous catalyst is 0.5%, the morphology of the platinum-based heterogeneous catalyst is spherical, and the particle size range is 0.2mm~4mm; the morphology of the platinum-based heterogeneous catalyst can also be columnar; after stable operation to the predetermined time, sampling is carried out at the discharge port, and the residual raw materials and product contents of the two steps before and after are analyzed to obtain the total conversion rate of the raw materials, and the results are listed in Table 1 below; the predetermined time is 50h, 100h or 200h; the hydrogen-ammonia mixed gas is the same as step 2;

[0081] Step 7, washing the system after the reaction in step 6 with saturated brine, separating the phases to obtain an organic phase, drying the organic phase, filtering, and evaporating to dryness to obtain a crude product; the drying is drying with anhydrous sodium sulfate;

[0082] Step eight, recrystallizing the crude product to obtain rilmenidine; the solvent for the recrystallization is ethyl acetate, or n-hexane; the melting point of the recrystallization is 105-107°C.

[0083] The NMR and mass spectrum of rilmenidine in this example are substantially the same as those in Example 1.

[0084] Example 3

[0085] This embodiment provides a continuous preparation method of rilmenidine, which specifically comprises:

[0086] Step 1, mixing dicyclopropyl ketone with an organic solvent to obtain a feed liquid A; the organic solvent is toluene; the concentration of dicyclopropyl ketone in the feed liquid A is 20 g / L;

[0087] Step 2, preheating the hydrogen-ammonia mixture to 80°C and then passing it into a fixed bed reactor I equipped with a palladium-based heterogeneous catalyst, until the pressure in the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst is 2.0MPa.G and maintained, setting the temperature of the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst to 80°C and maintaining it, preheating the feed liquid A to 80°C and passing it into the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst at a flow rate of 5mL / min for oximation hydrogenation reaction; the average residence time of the feed liquid A in the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst is The time interval is 4h; the volume ratio of hydrogen to ammonia in the hydrogen-ammonia mixed gas is 5:1, the mass of the palladium-based heterogeneous catalyst is 20g, the palladium-based heterogeneous catalyst is a palladium-based heterogeneous catalyst with activated carbon as a carrier supporting palladium, the mass percentage of palladium in the palladium-based heterogeneous catalyst is 5%, the palladium-based heterogeneous catalyst is spherical in shape, and the particle size range is 0.5mm-4mm; the palladium-based heterogeneous catalyst can also be columnar in shape; the hydrogen-ammonia mixed gas flow rate introduced by maintaining the pressure in the fixed bed reactor I containing the palladium-based heterogeneous catalyst is 30mL / min;

[0088] Step 3: Perform gas-liquid separation on the system after the reaction in step 2 to obtain a liquid phase system; the gas-liquid separation can separate hydrogen and ammonia for recycling;

[0089] Step 4, drying and degassing the liquid phase system to obtain a degassed system; the drying is performed using a 4A molecular sieve; the degassing is performed by bubbling degassing, the degassing is performed using nitrogen, the nitrogen flow rate is 100 mL / min, and the degassing time is 2 h;

[0090] Step 5, mixing 2-oxazolidinone and a reaction aid solution with a co-solvent to obtain a feed solution B; the reaction aid solution is a tetrafluoroboric acid ether solution, the reaction aid is tetrafluoroboric acid, the co-solvent is anhydrous ethanol, the mass percentage of the tetrafluoroboric acid ether solution is 55%, the concentration of 2-oxazolidinone in the feed solution B is 8 g / L, and the molar ratio of 2-oxazolidinone to tetrafluoroboric acid is 1:4;

[0091] Step 6: Preheat nitrogen to 100 ° C and then pass it into a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst until the pressure in the fixed bed reactor II equipped with a platinum-based heterogeneous catalyst is 1 atm and maintained, set the temperature of the fixed bed reactor II equipped with a platinum-based heterogeneous catalyst to 100 ° C and maintain it, mix the system after degassing in step 4 and the feed liquid B in step 5 at a volume ratio of 1:1.05 to obtain a mixture, preheat the mixture to 100 ° C and then input it into a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst at a flow rate of 5 mL / min for substitution dehydrogenation reaction; the mixture is in a fixed bed reactor equipped with a platinum-based heterogeneous catalyst. The average residence time in the device II is 6h; the mass of the platinum heterogeneous catalyst is 20g, the platinum heterogeneous catalyst is a catalyst loaded with platinum on Al2O3 as a carrier, the mass percentage of platinum in the platinum heterogeneous catalyst is 2%, the morphology of the platinum heterogeneous catalyst is spherical, and the particle size range is 0.2mm~4mm; the morphology of the platinum heterogeneous catalyst can also be columnar; after stable operation for a predetermined time, sampling is performed at the discharge port, and the residual raw materials and product contents of the two steps before and after are analyzed to obtain the total conversion rate of the raw materials, and the results are listed in the following Table 1; the predetermined time is 50h, 100h or 200h; the hydrogen-ammonia mixed gas is the same as step 2;

[0092] Step 7, washing the system after the reaction in step 6 with saturated brine, separating the phases to obtain an organic phase, drying the organic phase, filtering, and evaporating to dryness to obtain a crude product; the drying is drying with anhydrous sodium sulfate;

[0093] Step eight, recrystallizing the crude product to obtain rilmenidine; the solvent for the recrystallization is ethyl acetate, or n-hexane; the melting point of the recrystallization is 105-107°C.

[0094] The NMR and mass spectrum of rilmenidine in this example are substantially the same as those in Example 1.

[0095] Example 4

[0096] This embodiment provides a continuous preparation method of rilmenidine, which specifically comprises:

[0097] Step 1, mixing dicyclopropyl ketone with an organic solvent to obtain a feed liquid A; the organic solvent is cyclohexane; the concentration of dicyclopropyl ketone in the feed liquid A is 30 g / L;

[0098] Step 2: preheat the hydrogen-ammonia mixture to 30°C and then pass it into a fixed bed reactor I equipped with a palladium-based heterogeneous catalyst, until the pressure in the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst is 1.5 MPa.G and maintained, set the temperature of the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst to 30°C and maintain it, preheat the feed liquid A to 30°C and then pass it into the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst at a flow rate of 0.5 mL / min for oximation hydrogenation reaction; the average residence time of the feed liquid A in the fixed bed reactor I equipped with a palladium-based heterogeneous catalyst is The volume ratio of hydrogen to ammonia in the hydrogen-ammonia mixture is 10:1, the mass of the palladium-based heterogeneous catalyst is 40 g, the palladium-based heterogeneous catalyst is a palladium-based heterogeneous catalyst with activated carbon as a carrier supporting palladium, the mass percentage of palladium in the palladium-based heterogeneous catalyst is 15%, the palladium-based heterogeneous catalyst is spherical in shape, and the particle size range is 0.5 mm to 4 mm; the palladium-based heterogeneous catalyst can also be columnar in shape; the hydrogen-ammonia mixture gas flow rate introduced to maintain the pressure in the fixed bed reactor I containing the palladium-based heterogeneous catalyst is 30 mL / min;

[0099] Step 3: Perform gas-liquid separation on the system after the reaction in step 2 to obtain a liquid phase system; the gas-liquid separation can separate hydrogen and ammonia for recycling;

[0100] Step 4, drying and degassing the liquid phase system to obtain a degassed system; the drying is performed using a 4A molecular sieve; the degassing is performed by bubbling degassing, the degassing is performed using nitrogen, the nitrogen flow rate is 100 mL / min, and the degassing time is 2 h;

[0101] Step 5, mixing 2-oxazolidinone and a reaction aid solution with a co-solvent to obtain a feed solution B; the reaction aid solution is a tetrafluoroboric acid ether solution, the reaction aid is tetrafluoroboric acid, the co-solvent is ethyl acetate, the mass percentage of the tetrafluoroboric acid ether solution is 55%, the concentration of 2-oxazolidinone in the feed solution B is 24 g / L, and the molar ratio of 2-oxazolidinone to tetrafluoroboric acid is 1:5;

[0102] Step 6: Preheat nitrogen to 60°C and then pass it into a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst until the pressure in the fixed bed reactor II equipped with a platinum-based heterogeneous catalyst is 1 atm and maintained, set the temperature of the fixed bed reactor II equipped with a platinum-based heterogeneous catalyst to 60°C and maintain it, mix the degassed system in step 4 and the feed liquid B in step 5 at a volume ratio of 1:1.2 to obtain a mixture, preheat the mixture to 60°C and then input it into a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst at a flow rate of 1 mL / min for substitution dehydrogenation reaction; the mixture is in a fixed bed reactor II equipped with a platinum-based heterogeneous catalyst The average residence time in the reaction mixture is 6h; the mass of the platinum heterogeneous catalyst is 60g, the platinum heterogeneous catalyst is a catalyst using Al2O3 as a carrier to load platinum, the mass percentage of platinum in the platinum heterogeneous catalyst is 5%, the morphology of the platinum heterogeneous catalyst is spherical, and the particle size range is 0.2mm-4mm; the morphology of the platinum heterogeneous catalyst can also be columnar; after stable operation for a predetermined time, sampling is performed at the discharge port, and the residual raw materials and product contents of the two steps before and after are analyzed to obtain the total conversion rate of the raw materials, and the results are listed in Table 1 below; the predetermined time is 50h, 100h or 200h; the hydrogen-ammonia mixed gas is the same as step 2;

[0103] Step 7, washing the system after the reaction in step 6 with saturated brine, separating the phases to obtain an organic phase, drying the organic phase, filtering, and evaporating to dryness to obtain a crude product; the drying is drying with anhydrous sodium sulfate;

[0104] Step eight, recrystallizing the crude product to obtain rilmenidine; the solvent for the recrystallization is ethyl acetate, or n-hexane; the melting point of the recrystallization is 105-107°C.

[0105] The NMR and mass spectrum of rilmenidine in this example are substantially the same as those in Example 1.

[0106] Example 5

[0107] This embodiment is the same as embodiment 1, except that in step 2, the fixed bed reactor uses a platinum-based heterogeneous catalyst under the same conditions.

[0108] Example 6

[0109] This embodiment is the same as embodiment 2, except that in step 2, the fixed bed reactor uses a ruthenium-based heterogeneous catalyst under the same conditions.

[0110] Example 7

[0111] This embodiment is the same as embodiment 3, except that in step 2, the fixed bed reactor uses a rhodium-based heterogeneous catalyst under the same conditions.

[0112] Example 8

[0113] This embodiment is the same as embodiment 1, except that in step 6, the fixed bed reactor uses a palladium-based heterogeneous catalyst under the same conditions.

[0114] Example 9

[0115] This embodiment is the same as embodiment 2, except that in step 6, the fixed bed reactor uses a ruthenium-based heterogeneous catalyst under the same conditions.

[0116] Example 10

[0117] This embodiment is the same as embodiment 3, except that in step 6, the fixed bed reactor uses a rhodium-based heterogeneous catalyst under the same conditions.

[0118] Embodiment 11

[0119] This embodiment is the same as embodiment 1, except that in step 2, the fixed bed reactor uses a platinum-based heterogeneous catalyst under the same conditions, and in step 6, the fixed bed reactor uses a palladium-based heterogeneous catalyst under the same conditions.

[0120] Example 12

[0121] This embodiment is the same as embodiment 2, except that in step 2, the fixed bed reactor uses a rhodium-based heterogeneous catalyst under the same conditions, and in step 6, the fixed bed reactor uses a ruthenium-based heterogeneous catalyst under the same conditions.

[0122] Example 13

[0123] This embodiment is the same as embodiment 3, with the difference being that in step 2, the fixed bed reactor uses a ruthenium-based heterogeneous catalyst under the same conditions, and in step 6, the fixed bed reactor uses a rhodium-based heterogeneous catalyst under the same conditions.

[0124] Embodiment 14

[0125] This embodiment provides a continuous preparation method of rilmenidine, which specifically comprises:

[0126] Step 1, mixing dicyclopropyl ketone with an organic solvent to obtain a feed liquid A; the organic solvent is anhydrous ethanol and acetonitrile in a volume ratio of 1:2; the concentration of dicyclopropyl ketone in the feed liquid A is 10 g / L;

[0127] Step 2: preheat the hydrogen-ammonia mixture to 30°C and then pass it into a fixed bed reactor I equipped with a first metal-supported heterogeneous catalyst, until the pressure in the fixed bed reactor I equipped with the first metal-supported heterogeneous catalyst is 0.1 MPa.G and maintained, set the temperature of the fixed bed reactor I equipped with the first metal-supported heterogeneous catalyst to 30°C and maintain it, preheat the feed liquid A to 30°C and then pass it into the fixed bed reactor I equipped with the first metal-supported heterogeneous catalyst at a flow rate of 0.1 mL / min for oximation hydrogenation reaction; the average residence time of the feed liquid A in the fixed bed reactor I equipped with the first metal-supported heterogeneous catalyst is 3h; The volume ratio of hydrogen to ammonia in the hydrogen-ammonia mixture is 10:1, the mass of the first metal-supported heterogeneous catalyst is 50 g, the first metal-supported heterogeneous catalyst is a first metal-supported heterogeneous catalyst using aluminum oxide as a carrier to support the metal, the first metal-supported heterogeneous catalyst is a palladium-supported catalyst and a rhodium-supported catalyst in a mass ratio of 2:1, the mass percentages of palladium and rhodium are 0.5% respectively, the first metal-supported heterogeneous catalyst is spherical in shape, and the particle size ranges from 0.5 mm to 4 mm; the hydrogen-ammonia mixture gas flow rate introduced by maintaining the pressure in the fixed bed reactor I equipped with the first metal-supported heterogeneous catalyst is 1 mL / min;

[0128] Step 3: Perform gas-liquid separation on the system after the reaction in step 2 to obtain a liquid phase system; the gas-liquid separation can separate hydrogen and ammonia for recycling;

[0129] Step 4, drying and degassing the liquid phase system to obtain a degassed system; the drying is performed using a 4A molecular sieve; the degassing is performed by bubbling degassing, the degassing is performed using nitrogen, the nitrogen flow rate is 100 mL / min, and the degassing time is 2 h;

[0130] Step 5, mixing 2-oxazolidinone and a reaction aid solution with a co-solvent to obtain a feed solution B; the reaction aid solution is a boron trifluoride ether solution, the reaction aid is boron trifluoride, the co-solvent is m-dichlorobenzene, the mass percentage of the boron trifluoride ether solution is 47%, the concentration of 2-oxazolidinone in the feed solution B is 8 g / L, and the molar ratio of 2-oxazolidinone to boron trifluoride is 1:1;

[0131] Step six, preheating nitrogen to 50 ° C and then passing it into a fixed bed reactor II containing a second metal-supported heterogeneous catalyst, until the pressure in the fixed bed reactor II containing the second metal-supported heterogeneous catalyst is 1atm and maintained, setting the temperature of the fixed bed reactor II containing the second metal-supported heterogeneous catalyst to 50 ° C and maintaining it, mixing the system after degassing in step 4 and the feed liquid B in step 5 in a volume ratio of 1:1 to obtain a mixture, preheating the mixture to 50 ° C and then inputting it into the fixed bed reactor II containing the second metal-supported heterogeneous catalyst at a flow rate of 0.1 mL / min for substitution dehydrogenation reaction; the average stop flow rate of the mixture in the fixed bed reactor II containing the second metal-supported heterogeneous catalyst is 2.5 %. The residence time is 10h; the mass of the second metal-supported heterogeneous catalyst is 100g, the second metal-supported heterogeneous catalyst is a catalyst with Al2O3 as a carrier to support the metal, the second metal-supported heterogeneous catalyst is a palladium-supported catalyst and a platinum-supported catalyst with a mass ratio of 1:1, the mass percentage of palladium and platinum is 0.1% respectively, the morphology of the second metal-supported heterogeneous catalyst is spherical, and the particle size range is 0.2mm-4mm; after stable operation to the predetermined time, sampling is performed at the discharge port, and the residual raw materials and product content of the two steps before and after are analyzed to obtain the total conversion rate of the raw materials, and the results are listed in Table 1 below; the predetermined time is 50h, 100h or 200h; the hydrogen-ammonia mixed gas is the same as step 2;

[0132] Step 7, washing the system after the reaction in step 6 with saturated brine, separating the phases to obtain an organic phase, drying the organic phase, filtering, and evaporating to dryness to obtain a crude product; the drying is drying with anhydrous sodium sulfate;

[0133] Step eight, recrystallizing the crude product to obtain rilmenidine; the solvent for the recrystallization is ethyl acetate, or n-hexane; the melting point of the recrystallization is 105-107°C.

[0134] The NMR and mass spectrum of rilmenidine in this example are substantially the same as those in Example 1.

[0135] Embodiment 15

[0136] This embodiment provides a continuous preparation method of rilmenidine, which specifically comprises:

[0137] Step 1, mixing dicyclopropyl ketone with an organic solvent to obtain a feed liquid A; the organic solvent is n-pentane, toluene and n-heptane in a volume ratio of 2:1:1; the concentration of dicyclopropyl ketone in the feed liquid A is 50 g / L;

[0138] Step 2: preheat the hydrogen-ammonia mixture to 60°C and then pass it into a fixed bed reactor I equipped with a first metal-supported heterogeneous catalyst until the pressure in the fixed bed reactor I equipped with the first metal-supported heterogeneous catalyst is 2.0 MPa.G and maintained, set the temperature of the fixed bed reactor I equipped with the first metal-supported heterogeneous catalyst to 60°C and maintain it, preheat the feed liquid A to 60°C and then pass it into the fixed bed reactor I equipped with the first metal-supported heterogeneous catalyst at a flow rate of 5 mL / min for oximation hydrogenation reaction; the average residence time of the feed liquid A in the fixed bed reactor I equipped with the first metal-supported heterogeneous catalyst is 3h; The volume ratio of hydrogen and ammonia in the hydrogen-ammonia mixture is 1:1, the mass of the first metal-supported heterogeneous catalyst is 1g, the first metal-supported heterogeneous catalyst is a first metal-supported heterogeneous catalyst using silicon oxide as a carrier to support metal, the first metal-supported heterogeneous catalyst is a palladium-supported catalyst and a platinum-supported catalyst in a mass ratio of 1:1, and the mass percentages of palladium and platinum are 10% respectively; the first metal-supported heterogeneous catalyst has a spherical morphology and a particle size range of 0.5mm to 4mm; the hydrogen-ammonia mixture gas flow rate introduced to maintain the pressure in the fixed bed reactor I containing the first metal-supported heterogeneous catalyst is 50mL / min;

[0139] Step 3: Perform gas-liquid separation on the system after the reaction in step 2 to obtain a liquid phase system; the gas-liquid separation can separate hydrogen and ammonia for recycling;

[0140] Step 4, drying and degassing the liquid phase system to obtain a degassed system; the drying is performed using a 4A molecular sieve; the degassing is performed by bubbling degassing, the degassing is performed using nitrogen, the nitrogen flow rate is 100 mL / min, and the degassing time is 2 h;

[0141] Step 5, mixing 2-oxazolidinone and a reaction aid solution with a co-solvent to obtain a feed solution B; the reaction aid solution is a boron trifluoride ether solution, the reaction aid is boron trifluoride, the co-solvent is xylene, the mass percentage of the boron trifluoride ether solution is 47%, the concentration of 2-oxazolidinone in the feed solution B is 40 g / L, and the molar ratio of 2-oxazolidinone to boron trifluoride is 1:3;

[0142] Step 6: Preheat nitrogen to 70°C and then pass it into a fixed bed reactor II containing a second metal-supported heterogeneous catalyst until the pressure in the fixed bed reactor II containing the second metal-supported heterogeneous catalyst is 1 atm and maintained, set the temperature of the fixed bed reactor II containing the second metal-supported heterogeneous catalyst to 70°C and maintain it, mix the degassed system in step 4 and the feed liquid B in step 5 at a volume ratio of 1:1.15 to obtain a mixture, preheat the mixture to 70°C and then input it into a fixed bed reactor II containing a second metal-supported heterogeneous catalyst at a flow rate of 4 mL / min for substitution dehydrogenation reaction; the mixture is in a fixed bed reactor II containing a second metal-supported heterogeneous catalyst. The average residence time is 8h; the mass of the second metal-supported heterogeneous catalyst is 2g, the second metal-supported heterogeneous catalyst is a catalyst with Al2O3 as a carrier to support the metal, the second metal-supported heterogeneous catalyst is a palladium-supported catalyst and a platinum-supported catalyst with a mass ratio of 2:1, the mass percentage of palladium and platinum is 10% respectively, the morphology of the second metal-supported heterogeneous catalyst is spherical, and the particle size range is 0.2mm-4mm; after stable operation for a predetermined time, sampling is performed at the discharge port, and the residual raw materials and product content of the two steps before and after are analyzed to obtain the total raw material conversion rate, and the results are listed in Table 1 below; the predetermined time is 50h, 100h or 200h; the hydrogen-ammonia mixed gas is the same as step 2;

[0143] Step 7, washing the system after the reaction in step 6 with saturated brine, separating the phases to obtain an organic phase, drying the organic phase, filtering, and evaporating to dryness to obtain a crude product; the drying is drying with anhydrous sodium sulfate;

[0144] Step eight, recrystallizing the crude product to obtain rilmenidine; the solvent for the recrystallization is ethyl acetate, or n-hexane; the melting point of the recrystallization is 105-107°C.

[0145] The NMR and mass spectrum of rilmenidine in this example are substantially the same as those in Example 1.

[0146] Example 16

[0147] This embodiment provides a continuous preparation system of rilmenidine, such as Figure 1 As shown, it includes a first material tank 1, a fixed bed reactor I3 for carrying out oximation hydrogenation reaction, a gas-liquid separation tank 5 and a degassing tower 7 which are connected in sequence, and a fixed bed reactor II4 for carrying out substitution dehydrogenation reaction which is connected to the discharge port of the degassing tower 7, and the feed port of the fixed bed reactor II4 is also connected to the second material tank 2;

[0148] The fixed bed reactor I3 is provided with a first catalyst bed layer, and the fixed bed reactor II4 is provided with a second catalyst bed layer.

[0149] The fixed bed reactor I3 and the fixed bed reactor II4 are both variable diameter reactors. Variable diameter reactors are commonly used variable diameter reactors in the art, and each includes a straight section and two variable diameter sections, and the two variable diameter sections are respectively connected to the two ends of the diameter section. In the present invention, the height-to-diameter ratio of the straight section of the variable diameter reactor used is 5 to 50, preferably 10 to 40, and more preferably 10 to 30. The height-to-diameter ratio of the straight section is the ratio of the distance between the lowest cross section and the highest cross section of the straight section to the inner diameter of the straight section, and the ratio of the length of the straight section to the total length of the variable diameter section is (30 to 40):1;.

[0150] The first catalyst bed and the second catalyst bed are both bed structures formed by stacking corresponding catalysts; in the present invention, the height of the first catalyst bed and the second catalyst bed are both 10 cm to 80 cm; the catalysts in the first catalyst bed and the second catalyst bed include one or more of rhodium-based heterogeneous carrier catalysts, ruthenium-based heterogeneous carrier catalysts, palladium-based heterogeneous carrier catalysts and platinum-based heterogeneous carrier catalysts.

[0151] Comparative Example 1

[0152] This comparative example provides a discontinuous preparation method of rilmenidine, which adopts a stirred tank reactor instead of a fixed bed reactor, and specifically comprises:

[0153] Step 1, under nitrogen protection, adding liquid A and a palladium-based heterogeneous catalyst to a stirred tank reactor; the liquid A is the same as that in step 1 of Example 1; the palladium-based heterogeneous carrier catalyst is the same as the catalyst in step 2 of Example 1, the only difference being that the morphology is powder;

[0154] Step 2, replace the nitrogen in the stirred tank reactor with hydrogen 3 times, and after emptying, fill it with hydrogen and ammonia mixed gas, keep the pressure and temperature of the stirred tank reactor consistent with Example 1, and react for 3 hours; the flow rate and amount of the hydrogen and ammonia mixed gas charged are the same as those in Example 1;

[0155] Step 3, drying and degassing the system after the reaction in step 2 to obtain a degassed system;

[0156] Step 4: under nitrogen protection, add the degassed system of step 3 and feed liquid B in a volume ratio of 1:1.1 to a stirred tank reactor, and place a platinum-based heterogeneous catalyst; the feed liquid B is the same as the feed liquid B of step 5 of Example 1; the platinum-based heterogeneous catalyst is the same as Example 1, the only difference being that the morphology is powder;

[0157] Step 5: The nitrogen pressure and temperature of the stirred tank reactor were maintained consistent with those in step 6 of Example 1, and the reaction was continued for 4 hours. After the reaction was completed, samples were taken to analyze the remaining raw materials and product contents in the two steps before and after to obtain the total conversion rate of the raw materials. The results are listed in Table 1 below.

[0158] Step 6: Wash the reaction system with saturated brine, separate the phases to obtain an organic phase, dry the organic phase, filter, and evaporate to dryness to obtain a crude product;

[0159] Step 7: Recrystallize the crude product to obtain rilmenidine; calculate the product yield, and detect the purity of the product after recrystallization. The results are listed in Table 1 below.

[0160] Comparative Example 2

[0161] This comparative example is the same as comparative example 1, except that the catalysts used in step 1 and step 4 are the catalysts recovered from the reaction in comparative example 1.

[0162] Comparative Example 3

[0163] This comparative example is the same as comparative example 1, except that the catalysts used in step 1 and step 4 are the catalysts recovered from the reaction in comparative example 2.

[0164] Comparative Example 4

[0165] This comparative example is the same as comparative example 1, except that the catalysts used in step 1 and step 4 are the catalysts recovered from the reaction in comparative example 3.

[0166] Comparative Example 5

[0167] This comparative example is the same as comparative example 1, except that the catalysts used in step 1 and step 4 are the catalysts recovered from the reaction in comparative example 4.

[0168] Comparative Example 6

[0169] This comparative example is the same as comparative example 1, except that the amount of raw materials and parameters are the same as those of Example 13 instead of Example 1.

[0170] Comparative Example 7

[0171] This comparative example is the same as comparative example 6, except that the catalysts used in step 1 and step 4 are the catalysts recovered from the reaction in comparative example 6.

[0172] Comparative Example 8

[0173] This comparative example is the same as comparative example 6, except that the catalysts used in step 1 and step 4 are the catalysts recovered from the reaction in comparative example 7.

[0174] Comparative Example 9

[0175] This comparative example is the same as comparative example 6, except that the catalysts used in step 1 and step 4 are the catalysts recovered from the reaction in comparative example 8.

[0176] Comparative Example 10

[0177] This comparative example is the same as comparative example 6, except that the catalysts used in step 1 and step 4 are the catalysts recovered from the reaction in comparative example 9.

[0178] Performance Evaluation

[0179] Table 1 Reaction results of continuous preparation of rilmenidine

[0180]

[0181]

[0182] The conversion rate and yield in Table 1 are the yield and conversion rate of liquid A converted into the product when the equipment is running stably and continuously for a preset time, and the purity is the purity of the corresponding product after recrystallization.

[0183] According to Table 1, the present invention continuously prepares rilmenidine by hydrogenating dicyclopropyl ketone and then replacing and dehydrating it with 2-oxazolidinone, and the total conversion rate of the reaction can be stabilized at 90.7% at the highest after continuous operation for 200 hours. Combining Example 1, Example 13, Comparative Example 1 and Comparative Example 6, it can be seen that the dual fixed bed reactor series system of the present invention is used to continuously prepare rilmenidine, and the yield and selectivity of the reaction are basically the same as those of the autoclave reaction of the comparative example, indicating that the new process of the dual fixed bed reactor series system of the present invention has no effect on the yield and conversion rate of the synthesis of rilmenidine.

[0184] In addition, based on Examples 1 to 13, the present invention further discovered that not all precious metal heterogeneous catalysts are suitable for the method for continuously preparing rilmenidine of the present invention. For example, when the heterogeneous catalyst in step six of the process is Ru, the reaction yield and conversion rate are significantly reduced. On this basis, when the heterogeneous catalyst in the reaction of step two is Rh, the effect of the continuous reaction will be further affected.

[0185] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any way. Any simple modification, change and equivalent structural change made to the above embodiment according to the technical essence of the invention still falls within the protection scope of the technical solution of the present invention.

Claims

1. A continuous preparation method of rilmenidine, characterized in that: The synthetic route of the method is as follows:

2. The continuous preparation method of rilmenidine according to claim 1, characterized in that: include: Step 1, mixing dicyclopropyl ketone with an organic solvent to obtain a feed liquid A; Step 2, preheating the hydrogen-ammonia mixture to 30-80°C and then passing it into a fixed bed reactor I equipped with a heterogeneous catalyst until the pressure in the fixed bed reactor I equipped with a heterogeneous catalyst is 0.1-2MPa.G and maintained, setting the temperature of the fixed bed reactor I equipped with a heterogeneous catalyst to 30-80°C and maintaining it, preheating the feed liquid A to 30-80°C and then passing it into the fixed bed reactor I equipped with a heterogeneous catalyst at a flow rate of 0.1mL / min-5mL / min for oximation hydrogenation reaction; Step 3, separating the gas-liquid phase of the system after the reaction in step 2 to obtain a liquid phase system; Step 4, drying and degassing the liquid phase system to obtain a degassed system; Step 5, mixing 2-oxazolidinone and the reaction aid solution with the co-solvent to obtain a feed solution B; Step 6, preheating nitrogen to 50-100° C. and then passing it into a fixed bed reactor II filled with a heterogeneous catalyst until the pressure in the fixed bed reactor II filled with a heterogeneous catalyst is 1 atm and maintained, setting the temperature of the fixed bed reactor II filled with a heterogeneous catalyst to 50-100° C. and maintaining it, mixing the degassed system in step 4 and the feed liquid B in step 5 at a volume ratio of 1: (1-1.2) to obtain a mixture, preheating the mixture to 50-100° C. and then inputting it into a fixed bed reactor II filled with a heterogeneous catalyst at a flow rate of 0.1 mL / min-5 mL / min for substitution dehydrogenation reaction; Step 7, washing the system after the reaction in step 6, separating the phases to obtain an organic phase, drying the organic phase, filtering, and evaporating to dryness to obtain a crude product; Step eight, recrystallizing the crude product to obtain rilmenidine.

3. The continuous preparation method of rilmenidine according to claim 1, characterized in that: In step 1, the organic solvent is one or more of alcohols, ethers, nitriles, esters, alkanes, halogenated hydrocarbons and aromatic hydrocarbons; the alcohol organic solvent is methanol, anhydrous ethanol, isopropanol or tert-butanol; the ether organic solvent is ethyl ether, tetrahydrofuran, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether; the nitrile organic solvent is acetonitrile or propionitrile; the ester organic solvent is methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, isopentyl acetate, methyl propionate, ethyl propionate, propyl propionate, dimethyl carbonate, diethyl carbonate or ethyl methyl carbonate; the alkane organic solvent is n-pentane, n-heptane, n-hexane, cyclohexane or petroleum ether; the halogenated hydrocarbon organic solvent is dichloromethane or 1,2-dichloroethane; the aromatic hydrocarbon organic solvent is benzene, toluene, xylene, chlorobenzene, o-dichlorobenzene, m-dichlorobenzene or p-dichlorobenzene.

4. The continuous preparation method of rilmenidine according to claim 1, characterized in that: In step 1, the concentration of dicyclopropyl ketone in the feed liquid A is 5 to 50 g / L.

5. The continuous preparation method of rilmenidine according to claim 1, characterized in that: In step 2, the average residence time of liquid A in the fixed bed reactor I containing a heterogeneous catalyst is 3 to 5 h, and the volume ratio of hydrogen to ammonia in the hydrogen-ammonia mixture is (1 to 10): 1; in step 2, the flow rate of the hydrogen-ammonia mixture is 1 to 50 mL / min; in step 2, the mass of the heterogeneous catalyst is 1 to 50 g; in step 2, the heterogeneous catalyst is a metal-supported heterogeneous catalyst, and the mass percentage of the metal in the metal-supported heterogeneous catalyst is 0.5% to 15%; in step 2, the heterogeneous catalyst has a spherical or columnar morphology, a particle size range of 0.5 mm to 4 mm, and the heterogeneous catalyst is one or two of a rhodium-based heterogeneous carrier catalyst, a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst, and a platinum-based heterogeneous carrier catalyst.

6. The continuous preparation method of rilmenidine according to claim 1, characterized in that: In step 5, the reaction aid solution is a reaction aid solution obtained by dissolving a reaction aid in ether, and the reaction aid is boron trifluoride or tetrafluoroboric acid; in step 5, the concentration of 2-oxazolidinone in the feed solution B is 4 to 40 g / L, and the molar ratio of 2-oxazolidinone to the reaction aid is 1:(1 to 5).

7. The continuous preparation method of rilmenidine according to claim 1, characterized in that: In step 5, the cosolvent is one or more of alcohols, ethers, nitriles, esters, alkanes, halogenated hydrocarbons and aromatic hydrocarbons; the alcohol cosolvent is methanol, anhydrous ethanol, isopropanol or tert-butanol; the ether cosolvent is ether, tetrahydrofuran, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether; the nitrile cosolvent is acetonitrile or propionitrile; the ester cosolvent is methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, isopentyl acetate, methyl propionate, ethyl propionate, propyl propionate, dimethyl carbonate, diethyl carbonate or ethyl methyl carbonate; the alkane cosolvent is n-pentane, n-heptane, n-hexane, cyclohexane or petroleum ether; the halogenated hydrocarbon cosolvent is dichloromethane or 1,2-dichloroethane; the aromatic hydrocarbon cosolvent is benzene, toluene, xylene, chlorobenzene, o-dichlorobenzene, m-dichlorobenzene or p-dichlorobenzene.

8. The continuous preparation method of rilmenidine according to any one of claims 1 to 6, characterized in that: In step six, the average residence time of the mixture in the fixed bed reactor II containing a heterogeneous catalyst is 4 to 10 hours; in step six, the mass of the heterogeneous catalyst is 2 g to 100 g; in step six, the heterogeneous catalyst is a metal-supported heterogeneous catalyst, and the mass percentage of the metal in the metal-supported heterogeneous catalyst is 0.1% to 10%; in step six, the heterogeneous catalyst has a spherical or columnar morphology, a particle size range of 0.2 mm to 4 mm, and the heterogeneous catalyst is one or two of a rhodium-based heterogeneous carrier catalyst, a ruthenium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst and a platinum-based heterogeneous carrier catalyst.

9. The continuous preparation method of rilmenidine according to claim 7, characterized in that: In step six, the heterogeneous catalyst is one or two of a rhodium-based heterogeneous carrier catalyst, a palladium-based heterogeneous carrier catalyst and a platinum-based heterogeneous carrier catalyst.

10. A continuous preparation system of rilmenidine, characterized in that: The system comprises a fixed bed reactor I (3) for carrying out oximation hydrogenation reaction and a fixed bed reactor II (4) for carrying out substitution dehydrogenation reaction, wherein the fixed bed reactor I (3) is connected to the fixed bed reactor II (4).

Citation Information

Patent Citations

  • Oxazoline metal compound, preparation method thereof and application of oxazoline metal compound as catalyst

    CN108864166A

  • Method for preparing rilrnenidine

    CN1629144A